Cargando…

Efficacy and safety of therapy of chronic hepatitis B with telbivudine (LdT) in patients with HIV-infection without HAART

Detalles Bibliográficos
Autores principales:	Tsarenko, SP, Kravchenko, AV, Kanestri, VG, Maximov, SL
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112993/ http://dx.doi.org/10.1186/1758-2652-13-S4-P209

Ejemplares similares

Enfuvirtide in therapy at patients with HIV-infection and tuberculosis
por: Kravchenko, AV, et al.
Publicado: (2010)

Mortality of hospital or community-acquired Legionnaires’ disease (LD): a prospective study
por: Cronenberger, SP, et al.
Publicado: (2011)

Oral lesions among HIV seropositive individuals in an era of generic HAART: markers of HAART efficacy?
por: Vasudevan, Janani, et al.
Publicado: (2012)

Trends in human papillomavirus (HPV) infection among HIV-positive women in the pre-HAART and HAART era in a Nigerian clinic
por: Onigbogi, MO, et al.
Publicado: (2010)

Safety and efficacy of telbivudine for the treatment of chronic hepatitis B
por: Osborn, Melissa K
Publicado: (2009)

HIV-1 infection in dendritic cells in HAART suppressed patients
por: Maldonado, lrvin M, et al.
Publicado: (2006)

Mesenteric fat thickness in a group of HIV patients on HAART
por: Lee, SS, et al.
Publicado: (2010)

Characteristic of HIV/AIDS infected patients at the detection and HAART initiation
por: Holban, Tiberiu, et al.
Publicado: (2014)

High level of adherence to HAART among refugees and internally displaced persons on HAART in western equatorial region of Southern Sudan
por: Salami, O, et al.
Publicado: (2010)

Anal and cervical cytologic abnormalities among HIV-infected women in the era of HAART
por: Kojic, EM, et al.
Publicado: (2009)

The prognosis of patients with dissociated virological and immunological responses to HAART
por: Jevtovic, DJ, et al.
Publicado: (2010)

Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
por: Tossonian, HK, et al.
Publicado: (2010)

Effective HAART reduces the incidence of high grade cervical neoplasia in HIV positive women
por: Morris-Harris, Deborah, et al.
Publicado: (2012)

Prevalence and risk factors for chronic obstructive lung disease in HIV-infected patients in the HAART era
por: Madeddu, G, et al.
Publicado: (2010)

Effectiveness of pegylated interferon alfa plus HAART in HIV/HBV treatment-naïve coinfected patients
por: Mata-Marín, JA, et al.
Publicado: (2010)

The 10 year safety and efficacy of tenofovir disoproxil fumarate (TDF)-containing once-daily highly active antiretroviral therapy (HAART)
por: Cassetti, I, et al.
Publicado: (2010)

Interventions to promote adherence to Antiretroviral Therapy (HAART) among adult patients at an HIV/AIDS program in Uganda
por: Muhumuza, Simon, et al.
Publicado: (2010)

Factors associated with treatment modification during the first year of contemporary HAART
por: Martin, N, et al.
Publicado: (2010)

High preterm delivery rates associated with initiation of HAART during pregnancy
por: Taylor, GP, et al.
Publicado: (2010)

Efficacy and safety of TDF/FTC-containing, first-line HAART in clinical practice: 3-year data from the German outpatient cohort
por: van Lunzen, J, et al.
Publicado: (2010)

Efficacy and safety of TDF+FTC+EFV in naïve patients initiating HAART; an observational study comparing Atripla Vs Truvada/Sustiva exposure
por: Sanchez, Carlos Alberto, et al.
Publicado: (2010)

Impact of timing HAART initiation on immune status and clinical course in the cohort of the German competence network for HIV/AIDS
por: Plettenberg, A, et al.
Publicado: (2010)

Relationship between dynamics of Epstein-Barr virus and immune activation in HIV-1 infected subjects in the HAART era
por: Cattelan, AM, et al.
Publicado: (2010)

Home visiting to an HIV positive patient prior to initiation of HAART has Lasting impact on their adherence. TASO Experience
por: Odeke, Emmanuel, et al.
Publicado: (2010)

Genetic variability and drug resistance mutations in HIV-1 infected individuals on HAART or drug naïve in Limbe, Cameroon
por: Agyingi, L, et al.
Publicado: (2012)

Prevalence of HPV in the oral cavity of HIV seropositive Indian women undergoing HAART
por: Mukherjee, Jaya, et al.
Publicado: (2014)

HAART restores the frequency of regulatory T cells (Tregs) among HIV/AIDS patients
por: Suthandhira, M, et al.
Publicado: (2014)

Generalized tuberculosis in HIV-infected patients with AIDS
por: Zimina, VN, et al.
Publicado: (2010)

Factors associated with non-adherence to HAART in HIV-positive pregnant women during pregnancy, peri- and postpartum in Lima, Peru
por: Tejada, Romina, et al.
Publicado: (2010)

Immune response after vaccination of HIV infected individuals receiving HAART with overlapping gag peptides pulsed on autologous cells
por: Kløverpris, H, et al.
Publicado: (2012)

P16-49. Broad types of cytokines secreted by Gag-specific T cells from HIV infected patients on HAART
por: Montes, M, et al.
Publicado: (2009)

Zinc is an inhibitor of the LdtR transcriptional activator
por: Pagliai, Fernando A., et al.
Publicado: (2018)

Five-year outcomes of HAART at a non-governmental treatment center in Lima, Peru
por: Castillo, N, et al.
Publicado: (2010)

LD(50 )values of ISS or NISS from the Chinese Trauma Data Bank and their application in predicting post-trauma sepsis
por: Liang, Huaping, et al.
Publicado: (2013)

P168 Metastatic mo ld infections after COVID-19: the mo ld time -bomb
por: Soman, Rajeev, et al.
Publicado: (2022)

Therapy of the patients with HIV/TB infection and dynamics of level 'naïve' CD4-lymphocytes
por: Popova, AA, et al.
Publicado: (2010)

HIV/HAART and the brain — what's going on?
por: Portegies, P
Publicado: (2010)

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
por: Wang, Y, et al.
Publicado: (2013)

Immunodominant Anti-Gag SLYNTVATL Responses in HIV-patients With More Than Five Years of HAART-induced Undetectable Plasma Viremia
por: Remenar, Anica, et al.
Publicado: (2005)

Viral hepatitis amongst Saharia: a primitive tribe of Madhya Pradesh
por: Rao, VG, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5it0oq1ktiqflrvi5tdqj33nh3